Home › Companies › NEUEHEALTH INC. › 2023-2024
At NEUEHEALTH INC.'s shareholder meeting held May 2, 2024, in the 2023-2024 proxy season, 53 asset managers reported how they voted on 13 ballot items in their SEC Form N-PX filings, covering 167 separate fund positions. On the most widely held item on that ballot — To approve on a non-binding advisory basis the compensation of our named executive officers for… — NEUEHEALTH INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NEUEHEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 8, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and NEUEHEALTH INC.’s Form 8-K, filed May 8, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 2, 2024: 13 items on NEUEHEALTH INC.’s Form 8-K, filed May 8, 2024: 10 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore NEUEHEALTH INC. in the interactive database Compare manager voting policies
These tallies are NEUEHEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 8, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kedrick D. Adkins Jr. | 4,845,239 | -- | -- | 246,415 | 760,924 | 95% | Elected | — |
| Elect Director: Linda Gooden | 4,884,228 | -- | -- | 207,426 | 760,924 | 96% | Elected | — |
| Elect Director: Jeffrey R. Immelt | 4,895,070 | -- | -- | 196,584 | 760,924 | 96% | Elected | — |
| Elect Director: Manuel Kadre | 4,733,614 | -- | -- | 358,040 | 760,924 | 93% | Elected | — |
| Elect Director: Stephen Kraus | 5,041,792 | -- | -- | 49,862 | 760,924 | 99.0% | Elected | — |
| Elect Director: Mohamad Makhzoumi | 4,890,519 | -- | -- | 201,135 | 760,924 | 96% | Elected | — |
| Elect Director: Matthew G. Manders | 5,044,857 | -- | -- | 46,797 | 760,924 | 99.0% | Elected | — |
| Elect Director: G. Mike Mikan | 4,614,949 | -- | -- | 476,705 | 760,924 | 91% | Elected | — |
| Elect Director: Robert J. Sheehy | 4,650,749 | -- | -- | 440,905 | 760,924 | 91% | Elected | — |
| Elect Director: Andrew Slavitt | 5,046,805 | -- | -- | 44,849 | 760,924 | 99.1% | Elected | — |
| 2. Ratification of the appointment of Deloitte & Touche LLP | 5,759,477 | 58,849 | 34,252 | -- | -- | 99% | Approved | — |
| 3. Non-binding advisory vote on executive compensation | 4,852,047 | 237,271 | 2,336 | -- | 760,924 | 95% | Approved | — |
| 4. NeueHealth, Inc | 4,258,751 | 830,222 | 2,681 | -- | 760,924 | 84% | Approved | — |
Source: NEUEHEALTH INC., Form 8-K, filed with the SEC on May 8, 2024 — read the filing on EDGAR.
Each item below shows how the 53 asset managers that disclosed a NEUEHEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Andrew Slavitt
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Andrew Slavitt”): 5,046,805 for, 44,849 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: G. Mike Mikan
NEUEHEALTH INC.’s own tally for this item (“Elect Director: G. Mike Mikan”): 4,614,949 for, 476,705 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey R. Immelt
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Jeffrey R. Immelt”): 4,895,070 for, 196,584 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 23,287 for, 142,905 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 142,905 | Withhold |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kedrick D. Adkins Jr.
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Kedrick D. Adkins Jr.”): 4,845,239 for, 246,415 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 142,905 for, 23,287 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 0 | 0 | 0 | 23,259 | Withhold |
| John Hancock | 0 | 0 | 0 | 28 | Withhold |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Linda Gooden
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Linda Gooden”): 4,884,228 for, 207,426 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,164 for, 28 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 28 | Withhold |
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Manuel Kadre
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Manuel Kadre”): 4,733,614 for, 358,040 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 23,259 for, 142,933 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 142,905 | Withhold |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 28 | Withhold |
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Matthew G. Manders
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Matthew G. Manders”): 5,044,857 for, 46,797 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mohamad Makhzoumi
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Mohamad Makhzoumi”): 4,890,519 for, 201,135 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 23,287 for, 142,905 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 142,905 | Withhold |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert J. Sheehy
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Robert J. Sheehy”): 4,650,749 for, 440,905 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Stephen Kraus
NEUEHEALTH INC.’s own tally for this item (“Elect Director: Stephen Kraus”): 5,041,792 for, 49,862 withheld, per its Form 8-K filed May 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The ten directors standing for election to serve until the 2025 annual meeting of stockholders were elected based upon the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
84% Approved · of votes cast
Description as filed by funds: To approve the NeueHealth, Inc. Second Amended and Restated 2021 Omnibus Incentive Plan.
NEUEHEALTH INC.’s own tally for this item (“4. NeueHealth, Inc”): 4,258,751 for, 830,222 against — passed, per its Form 8-K filed May 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The NeueHealth, Inc. Second Amended and Restated 2021 Omnibus Incentive Plan was approved based upon the following votes:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 4 asset managers below reported 166,192 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 142,905 | 0 | 0 | Against |
| Fidelity | 0 | 23,259 | 0 | 0 | Against |
| John Hancock | 0 | 28 | 0 | 0 | Against |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Combines 6 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve on a non-binding advisory basis the compensation of our named executive officers for 2023.
NEUEHEALTH INC.’s own tally for this item (“3. Non-binding advisory vote on executive compensation”): 4,852,047 for, 237,271 against — passed, per its Form 8-K filed May 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers for 2023 was approved on a non-binding advisory basis based upon the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 142,905 | 0 | 0 | Against |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Fund voting reports, all 3 managers: 23,287 for, 142,905 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Deer Management Co. LLC | 988,856 | 10,261 | 101 | 0 | For |
| BlackRock | 72,513 | 0 | 0 | 0 | For |
| HARBOURVEST PARTNERS LLC | 52,720 | 0 | 0 | 0 | For |
| Blackstone Inc. | 45,916 | 0 | 0 | 0 | For |
| Renaissance | 40,670 | 0 | 0 | 0 | For |
| Legacy Wealth Asset Management, LLC | 29,906 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 25,131 | 0 | 0 | 0 | For |
| Northern Trust | 13,548 | 0 | 0 | 0 | For |
| State Street | 12,381 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 9,478 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 5,784 | 0 | 0 | 0 | For |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 2,647 | 0 | 0 | 0 | For |
| SCS Capital Management LLC | 0 | 1,859 | 0 | 0 | Against |
| Point72 | 1,697 | 0 | 0 | 0 | For |
| Vanguard | 0 | 1,373 | 0 | 0 | Against |
| RBC Capital Markets, LLC | 798 | 0 | 0 | 0 | For |
| Capital Group | 483 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 320 | 0 | 0 | 0 | For |
| Accredited Investors Inc. | 227 | 0 | 0 | 0 | For |
| Beacon Pointe Advisors, LLC | 0 | 218 | 0 | 0 | Against |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 187 | 0 | 0 | 0 | For |
| CAPITAL COUNSEL LLC/NY | 133 | 0 | 0 | 0 | For |
| RBC Dominion Securities Inc. | 130 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 85 | 0 | 0 | 0 | For |
| Citadel | 74 | 0 | 0 | 0 | For |
Institutional-manager reports, all 49 managers: 1,304,146 for, 13,965 against, 101 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.
NEUEHEALTH INC.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP”): 5,759,477 for, 58,849 against — passed, per its Form 8-K filed May 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 was ratified based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 3 asset managers below reported 166,192 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 142,905 | 0 | 0 | 0 | For |
| Fidelity | 23,259 | 0 | 0 | 0 | For |
| John Hancock | 28 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 8,224,541 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 1.74% |
| 2 | Fidelity | 0.28% |
| 3 | John Hancock | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Deer Management Co. LLC | 12.15% |
| 2 | BlackRock | 0.88% |
| 3 | HARBOURVEST PARTNERS LLC | 0.64% |
| 4 | Blackstone Inc. | 0.56% |
| 5 | Renaissance | 0.49% |
| 6 | Legacy Wealth Asset Management, LLC | 0.36% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.31% |
| 8 | Northern Trust | 0.16% |
| 9 | State Street | 0.15% |
| 10 | STIFEL NICOLAUS & CO INC \MO\ | 0.12% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| New Enterprise Associates 15, L.P. | — | 13D |
| NEA BH SPV, L.P. | — | 13D |
| Mohamad Makhzoumi | — | DEF14A |
| New Enterprise Associates and affiliated funds | — | DEF14A |
| Bessemer Venture Partners and affiliated funds | — | DEF14A |
| Adair Newhall | — | DEF14A |
| StepStone Group LP | — | 13D |
| Bessemer Venture Partners IX L.P. | — | 13G |
| G. Mike Mikan | — | DEF14A |
| Robert J. Sheehy | — | DEF14A |
Percentages above are of 8,224,541 shares outstanding, as reported by NEUEHEALTH INC. on its Form 10-Q dated May 2, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEUEHEALTH INC.’s 10-Q dated May 2, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
NEUEHEALTH INC. proxy season coverage: 2023-2024 (this page).
proxyvotesnow.com, “NEUEHEALTH INC. 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/neuehealth-inc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.